Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2017 Filed Apr 10, 2017 17:36 UTC |
Shah MihirChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001498865-17-000005 · primary_doc.xml · derivative · entry 1 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 18:11 UTC |
Hosseinion WarrenDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 23,363 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001498865-17-000008 · primary_doc.xml · derivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,363 Underlying: Common Stock · 23,363 shares Expires 2022-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 18:11 UTC |
Hosseinion WarrenDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 6,637 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001498865-17-000008 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,637 Underlying: Common Stock · 6,637 shares Expires 2027-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 17:59 UTC |
Vazquez AdrianChief Medical Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001498865-17-000007 · primary_doc.xml · derivative · entry 1 Vazquez Adrian · CIK 0001438326 · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 17:47 UTC |
Augusta GaryDirector · Chairman of the Board
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001498865-17-000006 · primary_doc.xml · derivative · entry 1 Augusta Gary · CIK 0001574651 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:16 UTC |
Shah MihirChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001676960-16-000002 · primary_doc.xml · derivative · entry 1 Shah Mihir · CIK 0001676960 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-12-14 F1 · derivative.exercise_date: The option is exercisable in equal monthly installments of 1/36th of the shares commencing December 14, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:42 UTC |
Vazquez AdrianDirector · Chief Medical Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 23,400 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001498865-16-000007 · primary_doc.xml · derivative · entry 1 Vazquez Adrian · CIK 0001438326 · Director · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,400 Underlying: Common Stock · 23,400 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vested as to two-thirds of the shares on February 15, 2016 and the balance vests at the rate of one-twelfth per month commencing on March 15, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 21:07 UTC |
NIHALANI SURESHDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000010 · primary_doc.xml · derivative · entry 1 NIHALANI SURESH · CIK 0001134366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 21:15 UTC |
Schmidt DavidDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000011 · primary_doc.xml · derivative · entry 1 Schmidt David · CIK 0001594029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:59 UTC |
Fawcett MarkDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000009 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:50 UTC |
Schreck EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000008 · primary_doc.xml · derivative · entry 1 Schreck Edward · CIK 0001572822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:32 UTC |
Augusta GaryDirector · Executive Chairman
|
GrantStock Option (right to buy) · Derivative | 93,500 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000006 · primary_doc.xml · derivative · entry 1 Augusta Gary · CIK 0001574651 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vested as to two-thirds of the shares on February 15, 2016 and the balance vests at the rate of one-twelfth per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:20 UTC |
Hosseinion WarrenDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 93,500 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001498865-16-000005 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · shares: The option vested as to two-thirds of the shares on February 15, 2016 and the balance vests at the rate of one-twelfth per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Mar 1, 2017 19:12 UTC |
Fawcett MarkDirector
|
GrantCommon Stock · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001498865-17-000004 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016. Read SEC document |
| September 14, 2016 Filed Mar 1, 2017 19:04 UTC |
NIHALANI SURESHDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001498865-17-000003 · primary_doc.xml · derivative · entry 1 NIHALANI SURESH · CIK 0001134366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016. Read SEC document |
| September 14, 2016 Filed Mar 1, 2017 18:57 UTC |
Schmidt DavidDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001498865-17-000002 · primary_doc.xml · derivative · entry 1 Schmidt David · CIK 0001594029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016. Read SEC document |
| September 14, 2016 Filed Mar 1, 2017 18:48 UTC |
Schreck EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001498865-17-000001 · primary_doc.xml · derivative · entry 1 Schreck Edward · CIK 0001572822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016. Read SEC document |
| September 14, 2016 Filed Apr 10, 2017 18:38 UTC Amendment |
Hosseinion WarrenDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 93,500 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001498865-17-000010 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires 2021-02-14 F1 · derivative.expiration_date: The purpose of this amendment is to correct the expiration date of the option. Read SEC document |
| September 14, 2016 Filed Apr 10, 2017 18:29 UTC Amendment |
Vazquez AdrianChief Medical Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 23,400 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001498865-17-000009 · primary_doc.xml · derivative · entry 1 Vazquez Adrian · CIK 0001438326 · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,400 Underlying: Common Stock · 23,400 shares Expires 2021-02-14 F1 · derivative.expiration_date: The purpose of this amendment is to correct the expiration date of the option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.